"we are calling for the immediate implementation of a statutory duty of candour for the health trusts."
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
. is putting his shoulder into legislation that would help others access the same sort of care he received when he suffered a stroke midway through his playing career.